Fingerprint
Dive into the research topics of 'Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF 301 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF 301 trial
Shalini Makawita, Ghassan K Abou-Alfa, Sameek Roychowdhury, Saeed Sadeghi, Ivan Borbath, Lipika Goyal, Allen Cohn, Angela Lamarca, Do Youn Oh, Teresa MacArulla, Rachna T Shroff, Michael Howland, Ai Li, Terry Cho, Amit Pande, Milind Javle
Research output: Contribution to journal › Review article › peer-review
57
Scopus
citations